Stay updated on Dupilumab in Children With Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Children With Asthma Clinical Trial page.

Latest updates to the Dupilumab in Children With Asthma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedResults for the study have been posted, including TEAEs and a range of efficacy and safety measures for the main study and the Japan sub-study through Week 64. Data include FEV1, IgE, ADA, dupilumab serum concentrations, and ACQ-IA/ACQ-5-IA outcomes.SummaryDifference3%

- Check22 days agoChange Detected- The lapse in government funding notice about potential data delays and outdated information has been removed. - It previously warned that updates and responses might be affected until appropriations are enacted.SummaryDifference0.2%

- Check36 days agoChange DetectedNo additions or deletions were detected. Observed changes appear to be non-substantive metadata updates; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange Detected- Added Cali, Colombia, 760043 as a study location and removed Santiago de Cali, Colombia, 760043.SummaryDifference0.0%

- Check57 days agoChange DetectedResults status updated from No Results Posted to Results Submitted, signaling that results are now available.SummaryDifference0.1%

- Check64 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to Dupilumab in Children With Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Children With Asthma Clinical Trial page.